Recent news on Advair Diskus

FDA Advisory Committee Finds Substantial Evidence To Support ...  -  May 8, 2007
Medical News Today (press release),An Advisory Committee to the US Food and Drug Administration (FDA) today unanimously agreed (11 to 0) that GlaxoSmithKline's Advair Diskus® 500/50

FDA Advisory Committee Finds Substantial Evidence to Support ...  -  May 2, 2007
PharmaLive.com (press release),Advair Diskus(R) 250/50 was approved in 2003 for the maintenance treatment of airflow obstruction in patients with COPD associated with chronic bronchitis.

Analysis: Asthma patients can cut dose  -  May 17, 2007
United Press InternationalThe researchers assigned 169 subjects to remain on that regimen, while assigning 165 patients to receive one daily dose of Advair Diskus (fluticasone plus

FDA Advisory Committee Finds Substantial Evidence to Support ...  -  May 9, 2007
Pharmaceutical Processing,An Advisory Committee to the FDA recently unanimously agreed (11 to 0) that GlaxoSmithKline's Advair Diskus® 500/50 (fluticasone propionate and salmeterol

FDA panel not sure GSK's Advair increases COPD survival  -  May 2, 2007
Pharma Times (subscription),...view that the highest dose of its asthma blockbuster Advair Diskus can increase survival rates for patients with chronic obstructive pulmonary disease.

FDA Advisory Committee Finds Substantial Evidence to Support ...  -  May 2, 2007
Compliance Home,...(May 1, 2007)-- An Advisory Committee to the US Food and Drug Administration (FDA) unanimously agreed (11 to 0) that GlaxoSmithKline's Advair Diskus(R)

GlaxoSmithKline Receives Japanese Approval For Two Major New ...  -  Apr 23, 2007
Medical News Today (press release),GlaxoSmithKline (GSK) today announced that it has received approval for Seretide/Advair Diskus (salmeterol and fluticasone proprionate combination) and

Japanese nod for GSK's Seretide/Advair and Arixtra  -  Apr 19, 2007
Pharma Times (subscription),GlaxoSmithKline has received approval in Japan for its key respiratory product Seretide/Advair Diskus and its anti-thrombotic Arixtra, a move which the

GlaxoSmithKline: Advair, Arixtra Receive Approval In Japan  -  Apr 18, 2007
Therapeutics Daily (subscription) (press release),LONDON (Dow Jones)--GlaxoSmithKline Wednesday announced that it has received approval for Seretide/Advair Diskus and Arixtra from the Ministry of Health,

Glaxo gets marketing OK for Advair and Arixtra in Japan  -  Apr 18, 2007
Forbes,Seretide/Advair will be branded Advair Diskus, and has been approved for adult patients with bronchial asthma. Glaxo said it will be the only combination

GlaxoSmithKline wins Japanese approval for bronchial asthma treatment  -  Apr 18, 2007
International Herald Tribune,LONDON: GlaxoSmithKline PLC said Wednesday it received approval for its Seretide/Advair Diskus and Arixtra bronchial asthma treatment in Japan.

Doctors Say Treating Condition Requires the Right Medicine and the ...  -  Apr 16, 2007
LA Downtown News Online,In 2005, the Food and Drug Administration requested the manufacturers of Advair diskus, Foradil Aerolizer and Servent diskus update their product labels

Pharma Sector: Few Newsmakers Of The Week - Basilea Glaxo ...  -  Feb 25, 2007
Trading Markets,Seretide/Advair sold as Advair Diskus is a combined treatment of fluticasone propionate, an inhaled corticosteroid and salmeterol, used to treat asthma and

IMS Health Reports 8.3% Growth In US Prescription Sales For 2006 ...  -  Mar 8, 2007
Trading Markets,GlaxoSmithKline's Advair Diskus posted sales of $3.9 billion in the year. Lipitor also led the top ten products by US dispensed prescriptions with scripts

Pharma Sector: Few Newsmakers Of The Week - Basilea Glaxo ...  -  25 Feb 2007
Trading Markets,Seretide/Advair sold as Advair Diskus is a combined treatment of fluticasone propionate, an inhaled corticosteroid and salmeterol, used to treat asthma and

Results From Landmark Study Suggest That Advair 500/50 Provides ...  -  Feb 22, 2007
PharmaLive.com (press release),Advair Diskus may increase this risk; therefore, bone mineral density assessment is recommended prior to starting Advair Diskus and periodically thereafter.

Market Report -- In Play (GSK)  -  Feb 22, 2007
MSN MoneyMedicine showed that patients with Chronic Obstructive Pulmonary Disease who took Advair Diskus 500/50 (fluticasone propionate and salmeterol inhalation

Combo Treatment Works Best for COPD  -  Feb 21, 2007
WebMDThe study looked at treatment with Advair Diskus 500/50, which combines an inhaled corticosteroid (Flovent) and a long-acting beta-agonist (Serevent).

lower steroid dose for asthmatic kids  -  Feb 13, 2007
NorthJersey.com,...to inhale Advair Diskus (a combination of fluticasone and the bronchodilator Serevent, or salmeterol) in the morning and Serevent again at night;

Beta-Agonists may cause thousands of asthma-related deaths each year  -  Jan 1, 2007
Health SentinelIn May 2005, the FDA requested manufacturers of these medications (Advair Diskus, Foradil Aerolizer, and Serevent Diskus) to update their product warning

Combination Therapy Reduces COPD Exacerbations  -  Jan 15, 2007
MedPage Today,Among patients with severe COPD prone to frequent exacerbations, Advair Diskus 500/50 (fluticasone plus salmeterol) reduced these episodes by 35% compared

GSK Submits Supplemental Drug Application for Advair in COPD  Oct 11, 2006
GlaxoSmithKline announced today that it has submitted a supplemental new drug application to the FDA to expand labeling for Advair Diskus(R) (fluticasone ... -International News Service, Advair(R) HFA Inhalation Aerosol Now Available  Oct 18, 2006
Advair(R), a medicine used in the treatment of asthma, became available in 2001 as a dry-powdered inhaler known as Advair Diskus (fluticasone propionate and ... -Medical News Today (press release), Advair(R) HFA Inhalation Aerosol Now Available  Oct 17, 2006
New Metered-Dose Inhaler Allows Asthma Patients to Receive Benefits of Advair Diskus(R) in Alternative Device RESEARCH TRIANGLE PARK, NC, Oct. ... -PR Newswire (press release), Glaxo seeks permission to sell asthma drug Advair as treatment for ...  Oct 11, 2006
North Carolina (AFX) - GlaxoSmithKline said it is seeking permission from the US Food and Drug Administration to market its asthma drug Advair Diskus as a ... -Forbes, GSK files for Advair as COPD therapy  Oct 11, 2006
The company said the application is supported by data from the three-year TORCH study and other studies of the inhalable Advair Diskus (fluticasone propionate ... -United Press International GSK Submits SDA for Advair in COPD  Oct 11, 2006
GlaxoSmithKline submitted a supplemental new drug application to expand labeling for Advair Diskus® (fluticasone propionate and salmeterol inhalation powder ... -Genetic Engineering News (press release), GlaxoSmithKline's (GSK) Advair HFA Inhalation Aerosol is Now ...  Oct 17, 2006
...nationwide. Advair, a medicine used in the treatment of asthma, became available in 2001 as a dry-powdered inhaler known as Advair Diskus. ... -StreetInsider.com (subscription), GSK rolls out new asthma inhaler  Oct 17, 2006
Previously, Advair was only available in a dry-powder form called Advair Diskus, leaving some asthma patients unable to use the drug. ... -Bizjournals.com, GSK Submits Supplemental Drug Application For Advair  Oct 11, 2006
GlaxoSmithKline PLC (GSK) submitted a supplemental new drug application to the Food and Drug Administration to market its Advair Diskus inhalation powder to ... -Therapeutics Daily (subscription) (press release), Glaxo launches new Advair inhaler in US  Oct 17, 2006
The new device will be sold alongside Advair Diskus, the existing dry-powdered inhaler launched in the US in 2001, giving patients a second option for how they ... -Reuters Glaxo submits supplemental Advair request in US  Oct 11, 2006
Plc (GSK.L: Quote, Profile, Research) said on Wednesday it has filed an application with US regulators to market its respiratory drug Advair Diskus as a ... -Reuters GlaxoSmithKline launches Advair HFA in US  Oct 17, 2006
The dry-powdered form of the drug, which is known as Advair Diskus and was launched in the US in 2001, would be sold alongside Advair HFA. ... -newratings.com Blunt argument  Oct 18, 2006
Alas, instead of puffing joints, I puff the Advair diskus, a flamboyantly purple asthma inhaler frequently, and ironically, advertised on the Oxygen channel. ... -Indiana Daily Student Advair Inhalers Safe in a Twice-Daily Regimen for Adult Asthmatics ...  Sep 18, 2006
Systemic exposure to fluticasone from Advair DISKUS (a combination fluticasone and salmeterol dry-powder inhaler) and a formulation of the 2 drugs administered ... -DG News

Asthma :: Fewer hospitalizations among asthma patients treated ...  -  Nov 17, 2006
SpiritIndia,An observational study of more than 64000 asthma patients demonstrated that patients receiving treatment with Advair Diskus (fluticasone propionate and

Novel Beta Agonist Indacaterol Safe and Effective in Short-Term ...  -  Nov 20, 2006
DG NewsCurrent combination treatments, such as fluticasone/salmeterol (Advair Diskus) and budesonide/formoterol (Symbicort) are given twice daily, and according to

Inhaled Budesonide/Formoterol Improves Asthma Control and Lung ...  -  Nov 13, 2006
DG News...been done with fluticasone and salmeterol, which are available together in an inhalation powder formulation (Advair Diskus), also used to treat asthma.

Oxygen mask causes nose bleeds  Aug 4, 2006
I have been diagnosed with Chronic Obstructive Pulmonary Disease. I have been using the Advair Diskus 250/50 for over two years. ... -Monterey County Herald

Asthma in Children and Adolescents  Jul 26, 2006
A single inhaler (Advair Diskus) that combines both long-acting beta2-agonists and corticosteroids is now available for children over age 12. ... -About - News & Issues

Biopsy Study Shows Long-Acting Beta2-Agonist And Low Steroid Dose ...  22 Jul 2006
The study, published in the July issue of the Journal of Allergy and Clinical Immunology (JACI), compared Advair Diskus (fluticasone propionate and salmeterol ... -Medical News Today

`Help Is Here' bus pushes prescription tips  22 Jul 2006
By Cedric Ricks. That means the 40-year-old Kalamazoo resident pays $289 a month out of pocket for her Advair Diskus inhaler. To ... -MLive.com

(PRN) - Sierra Bancorp Declares $0.14 Quarterly Cash Dividend ... ...  Jul 21, 2006
...(PRN) - Biopsy Study Shows Combination of Long-Acting Beta2-Agonist and Low Steroid Dose in Advair Diskus(R) 100/50mcg Maintains Control of Airway Inflammation ... -Bolsamania.com

GSK growth to bring 60 new posts  Jul 14, 2006
Mr Mustoe said: "The Advair Diskus is one of the fastest growing medicines in the US, with 28,000 people a day being prescribed it for the first time. ... -Herts Essex News



GlaxoSmithKline reaches agreement to update product label  Apr 7, 2006
..."[S]almeterol] one of the active ingredients in ADVAIR DISKUS may increase the risk of asthma-related death. Therefore, when treating ... - NewKerala.com

GSK Announces Positive Results of Seretide Survival Study In ...  Mar 28, 2006
...with COPD associated with bronchitis. Advair Diskus 50/500 is not approved for treatment of COPD in the US. Seretide/Advair 50/250 ... - Yahoo! News

COPD - Positive Results Of Seretide Survival Study  Mar 28, 2006
COPD associated with bronchitis. Advair Diskus 50/500 is not approved for treatment of COPD in the US. For International Media Seretide ... - Medical News Today

Cut Your Drug Costs  Feb 10, 2006
GlaxoSmithKline (nyse: GSK - news - people ), for example, offers discounts for a number of its drugs, from asthma medication Advair Diskus to Paxil CR, a ... - Forbes

Private plans have higher cost  Jan 31, 2006
One more: 60 doses of Advair Diskus for asthma sufferers cost $89.29 from Canada; $92.35 from the VA; $147.99 from drugstore.com; $153.97 from Costco; and ... - Stockton Record

Firms push back against drug-safety calls  Jan 19, 2006
November 21, 2005) -- While shares of GlaxoSmithKline slipped 5 percent in the wake of new label warnings for the British firm's asthma drugs Advair Diskus and ... - Science Daily

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional